Teratocarcinoma-Derived Growth Factor 1 (TDGF1) (Middle Region) Peptide
Quick Overview for Teratocarcinoma-Derived Growth Factor 1 (TDGF1) (Middle Region) Peptide (ABIN8113636)
Target
Origin
Source
Application
-
-
Protein Region
- Middle Region
-
Purpose
- TDGF1 Peptide - middle region
-
Sequence
- LRCFPQAFLP GCDGLVMDEH LVASRTPELP PSARTTTFML VGICLSIQSY
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-TDGF1 Antibody(ARP45440_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- TDGF1 (Teratocarcinoma-Derived Growth Factor 1 (TDGF1))
-
Background
-
Background Information: This gene encodes an epidermal growth factor-related protein that contains a cripto, FRL-1, and cryptic domain. The encoded protein is an extracellular, membrane-bound signaling protein that plays an essential role in embryonic development and tumor growth. Mutations in this gene are associated with forebrain defects. Pseudogenes of this gene are found on chromosomes 2, 3, 6, 8, 19 and X. Alternate splicing results in multiple transcript variants.
Alternative Symbols: CR, CRGF, CRIPTO, Cripto-1
-
Molecular Weight
- 21kDa
-
Gene ID
- 6997
-
NCBI Accession
- NP_003203
-
UniProt
- P13385
Target
-